RecruitingNot applicableNCT06387823

Efficacy and Safety of Sivelestat Sodium and Dexamethasone in the Treatment of ARDS

Studying Acute lung injury

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Peking Union Medical College Hospital
Principal Investigator
Bin Du, MD
Peking Union Medical College
Intervention
Sivelestat sodium(drug)
Enrollment
300 target
Eligibility
18 years · All sexes
Timeline
20242025

Study locations (4)

Collaborators

Peking University · Shanghai Huilun Pharmaceutical Co., Ltd.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06387823 on ClinicalTrials.gov

Other trials for Acute lung injury

Additional recruiting or active studies for the same condition.

See all trials for Acute lung injury

← Back to all trials